CDKAL1
Basic information
Region (hg38): 6:20534457-21232404
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CDKAL1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 26 | 28 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 26 | 3 | 3 |
Variants in CDKAL1
This is a list of pathogenic ClinVar variants found in the CDKAL1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-20546446-G-C | not specified | Uncertain significance (Jan 26, 2022) | ||
6-20546466-G-A | Likely benign (Dec 31, 2019) | |||
6-20546472-G-A | not specified | Uncertain significance (Dec 08, 2023) | ||
6-20548633-G-T | not specified | Uncertain significance (Oct 25, 2022) | ||
6-20548646-A-G | not specified | Uncertain significance (Nov 17, 2022) | ||
6-20649303-C-T | Benign (Mar 30, 2018) | |||
6-20660803-A-C | Type 2 diabetes mellitus | Uncertain significance (Sep 01, 2014) | ||
6-20661019-G-C | Obesity | risk factor (Dec 26, 2019) | ||
6-20679478-A-G | Type 2 diabetes mellitus | Uncertain significance (Sep 01, 2014) | ||
6-20739524-C-T | not specified | Uncertain significance (Jan 22, 2024) | ||
6-20739529-G-A | not specified | Uncertain significance (Jan 06, 2023) | ||
6-20739581-G-A | not specified | Uncertain significance (Sep 30, 2022) | ||
6-20739602-T-A | not specified | Uncertain significance (Mar 07, 2023) | ||
6-20758610-C-A | not specified | Uncertain significance (Oct 05, 2022) | ||
6-20781190-G-A | not specified | Uncertain significance (Nov 02, 2023) | ||
6-20781218-G-A | Benign (Dec 11, 2017) | |||
6-20781222-A-G | not specified | Uncertain significance (Jul 25, 2023) | ||
6-20846140-T-C | not specified | Uncertain significance (Feb 12, 2024) | ||
6-20955443-C-A | not specified | Uncertain significance (Nov 10, 2022) | ||
6-20955494-C-T | not specified | Uncertain significance (Oct 06, 2021) | ||
6-21065095-G-A | not specified | Uncertain significance (Jan 31, 2022) | ||
6-21065193-C-T | not specified | Uncertain significance (Aug 29, 2022) | ||
6-21108400-GA-G | Type 2 diabetes mellitus | not provided (-) | ||
6-21198076-A-T | Likely benign (Dec 17, 2018) | |||
6-21201134-T-C | not specified | Uncertain significance (Mar 19, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CDKAL1 | protein_coding | protein_coding | ENST00000274695 | 14 | 697948 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0160 | 0.984 | 125723 | 0 | 25 | 125748 | 0.0000994 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.66 | 229 | 311 | 0.735 | 0.0000157 | 3809 |
Missense in Polyphen | 61 | 119.35 | 0.51109 | 1477 | ||
Synonymous | -0.536 | 122 | 115 | 1.06 | 0.00000642 | 1093 |
Loss of Function | 3.58 | 9 | 30.2 | 0.298 | 0.00000156 | 362 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000304 | 0.000303 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000972 | 0.0000967 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000168 | 0.000163 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the methylthiolation of N6- threonylcarbamoyladenosine (t(6)A), leading to the formation of 2- methylthio-N6-threonylcarbamoyladenosine (ms(2)t(6)A) at position 37 in tRNAs that read codons beginning with adenine. {ECO:0000269|PubMed:20584901}.;
- Pathway
- miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;Vitamin D Receptor Pathway
(Consensus)
Recessive Scores
- pRec
- 0.247
Intolerance Scores
- loftool
- 0.585
- rvis_EVS
- -0.58
- rvis_percentile_EVS
- 18.72
Haploinsufficiency Scores
- pHI
- 0.234
- hipred
- N
- hipred_score
- 0.488
- ghis
- 0.594
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.305
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cdkal1
- Phenotype
- adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); homeostasis/metabolism phenotype; cellular phenotype; hematopoietic system phenotype; normal phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; vision/eye phenotype;
Zebrafish Information Network
- Gene name
- cdkal1
- Affected structure
- pancreatic B cell
- Phenotype tag
- abnormal
- Phenotype quality
- decreased area
Gene ontology
- Biological process
- tRNA modification;biological_process;tRNA methylthiolation;maintenance of translational fidelity
- Cellular component
- endoplasmic reticulum;endoplasmic reticulum membrane;rough endoplasmic reticulum;membrane;integral component of membrane
- Molecular function
- molecular_function;protein binding;N6-threonylcarbomyladenosine methylthiotransferase activity;metal ion binding;4 iron, 4 sulfur cluster binding;tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase